Cell Kinetics base_Aktie

Cell Kinetics base_Verbindlichkeiten 2025

Cell Kinetics base_Verbindlichkeiten

0 USD

components_StockPageHeader__3

CKNTF

components_StockPageHeader__4

IL0011098758

components_StockPageHeader__5

A0MV4W

pages_kennzahlen_[key]_[isin]__52

Cell Kinetics Aktienanalyse

pages_kennzahlen_[key]_[isin]__1

Cell Kinetics Ltd is a company specializing in the research and production of cell therapy products. The company was founded in 2020 and is based in London, United Kingdom. Cell Kinetics Ltd has a visionary mission that inspires the company to discover and develop groundbreaking solutions to improve people's health and well-being. The company aims to research, develop, and deliver therapies for serious diseases such as cancer and neurodegenerative disorders. The business model of Cell Kinetics Ltd is based on comprehensive research of new cell therapies and collaboration with academic partners to validate the clinical benefits of these therapies. The company has established partnerships with leading academic institutions and medical centers in Europe and the USA. Cell Kinetics Ltd works in various areas to achieve the goal of discovering and developing new therapies for serious diseases. An important focus of the company is the development of cell culture methods for the production and maintenance of therapeutic cells in large quantities. The company has extensive experience in developing artificial platforms for cell cultivation, including bioreactor-based cultivation, single-cell-sensitive cultivation, and the use of chemicals for cell cultivation. Another focus of Cell Kinetics Ltd is the development of carcinoma therapies. The company has developed a special technology for the production of T-cells that can be used to kill cancer cells. These T-cells are obtained from blood samples of cancer patients and cultivated in vitro. The company has also developed a technology that allows these T-cells to be modified to fight deadly diseases such as leukemia and lymphoma. Another focus of Cell Kinetics Ltd is the development of therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's. The company is developing special technologies to differentiate neural stem cells that can serve as a therapeutic tool for the treatment of these diseases. These neural stem cells can be used to repair damaged nerve cells. Cell Kinetics Ltd is proud to offer a range of products that can contribute to improving the health and well-being of patients. The company offers therapy products for cancer treatment, neurodegenerative diseases, and cardiovascular diseases, among others. In addition, the company also provides a wide range of services, including the development and production of cell therapy products, as well as artificial platforms for cell cultivation. Overall, Cell Kinetics Ltd has become a major player in the field of cell therapy and the development of therapies for serious diseases. The company is committed to continuing to develop groundbreaking discoveries and technologies to improve the lives of millions of people around the world. Cell Kinetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

pages_kennzahlen_[key]_[isin]__85

pages_kennzahlen_[key]_[isin]__79

pages_dividenden_[isin]_index__2

components_kpi_LiabilitiesFaqs_0

components_kpi_LiabilitiesFaqs_1

components_kpi_LiabilitiesFaqs_2

components_kpi_LiabilitiesFaqs_3

components_kpi_LiabilitiesFaqs_4

components_kpi_LiabilitiesFaqs_5

components_kpi_LiabilitiesFaqs_6

components_kpi_LiabilitiesFaqs_7

components_kpi_LiabilitiesFaqs_8

components_kpi_LiabilitiesFaqs_9

components_kpi_LiabilitiesFaqs_10

components_kpi_LiabilitiesFaqs_11

components_kpi_LiabilitiesFaqs_12

components_kpi_LiabilitiesFaqs_13

components_kpi_LiabilitiesFaqs_14

components_kpi_LiabilitiesFaqs_15

components_kpi_LiabilitiesFaqs_16

components_kpi_LiabilitiesFaqs_17

pages_aktie_[isin]_[key]_index_0

pages_aktie_[isin]_[key]_index_1

pages_aktie_[isin]_[key]_index_2

pages_aktie_[isin]_[key]_index_3

pages_aktie_[isin]_[key]_index_4

pages_aktie_[isin]_[key]_index_5

pages_aktie_[isin]_[key]_index_6

pages_aktie_[isin]_[key]_index_7

pages_aktie_[isin]_[key]_index_8

pages_aktie_[isin]_[key]_index_9

pages_aktie_[isin]_[key]_index_10

pages_aktie_[isin]_[key]_index_14

Wann musste ich die Aktien von Cell Kinetics kaufen, um die vorherige Dividende zu erhalten?

pages_aktie_[isin]_[key]_index_15

pages_aktie_[isin]_[key]_index_16

pages_aktie_[isin]_[key]_index_18

pages_aktie_[isin]_[key]_index_19

pages_aktie_[isin]_[key]_index_20

pages_aktie_[isin]_[key]_index_21

pages_aktie_[isin]_[key]_index_22

components_kpi_Savingsplan_0